Why the study?
Can a specific complement-fixation test using MEF1 virus antigen detect poliomyelitis virus infection in animal and human sera?
Can a specific complement-fixation test using MEF1 virus antigen detect poliomyelitis virus infection in animal and human sera?
A newly developed complement-fixation test using MEF1 virus antigen demonstrates specific reactivity in sera from animals and humans previously infected with poliomyelitis virus.
Answers are grounded in this paper and cite their sources.
May support serologic detection of prior poliomyelitis; leaves open diagnostic utility pending validation studies.
A complement-fixing antigen has been developed, using as source of material CNS tissue from newborn mice infected with the newborn mouse-adapted strain of the Lansing type, MEF1 virus. With this antigen, specific reactions have been obtained with sera from mice, cotton rats, and monkeys immunized with the Lansing-type virus, and from monkeys and chimpanzees convalescent from infection with this virus. Twenty-one of 35 human sera obtained from individuals convalescent from poliomyelitis were positive and 6 of 22 from apparently normal persons having Lansing-neutralizing antibody, while this held true for only 1 of 19 from those having no Lansing-neutralizing antibody. The fact that positive results were found in sera from patients having an infection with poliomyelitis virus of the Brunhilde type and at the same time no Lansing-neutralizing antibody brings up the possibility of the existence of a cross-reaction in complement fixation between the two types.
No takes yet. Share an insight, caveat, or question.
Casals et al. (1951) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: